Table 2.
Outcomes of the cardiac/muscular irAEs according to primary tumor
| N | Complete remission, n | Partial remission, n | Neither improvement nor death, n | Death, n | Not reported, n | |
|---|---|---|---|---|---|---|
| Melanoma (four uveal, one mucosal) | 67 | 27 | 12 | 1 | 25 | 2 |
| NSCLC | 35 | 10 | 5 | 3 | 15 | 2 |
| RCC | 7 | 2 | 1 | 0 | 4 | 0 |
| HNSCC | 4 | 1 | 0 | 0 | 2 | 1 |
| Cholangiocarcinoma | 1 | 0 | 0 | 0 | 0 | 1 |
| CRC | 1 | 0 | 1 | 0 | 0 | 0 |
| CSCC | 3 | 0 | 0 | 0 | 3 | 0 |
| Endometrial cancer | 2 | 1 | 1 | 0 | 0 | 0 |
| HCC | 2 | 2 | 0 | 0 | 0 | 0 |
| Mesothelioma | 1 | 0 | 0 | 0 | 1 | 0 |
| Pancreatic cancer | 4 | 1 | 1 | 0 | 0 | 2 |
| Prostate cancer | 1 | 1 | 0 | 0 | 0 | 0 |
| Thymoma | 1 | 1 | 0 | 0 | 0 | 0 |
| Thymic cancer | 4 | 1 | 0 | 0 | 2 | 1 |
| Urothelial cancer | 5 | 3 | 0 | 0 | 1 | 1 |
| Total | 138 | 50 | 21 | 4 | 53 | 10 |
CRC, colorectal carcinoma; CSCC, cutaneous squamous cell carcinoma; HCC, hepatocellular carcinoma; HNSCC, head-neck squamous cell carcinoma; irAEs, immune-related adverse events; NSCLC, non-small-cell lung cancer; RCC, renal cell carcinoma.